JMI LABS IS NOW PART OF LEARN MORE

Garenoxacin (BMS-284756) Activity Against 8,686 S. pneumoniae (SPN) Including Tentative Susceptibility Testing Criteria, Lead author: Jones RN, presented at 42nd annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 27 – 30, 2002, San Diego, California

View publication